Status:

WITHDRAWN

RU-486 in the Treatment of Bipolar Depression

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

Western Economic Diversification Canada

Stanley Medical Research Institute

Conditions:

Bipolar Depression

Eligibility:

All Genders

19-65 years

Phase:

PHASE2

Brief Summary

Bipolar disorder is a chronic and recurrent illness which involves episodes of mania and depression. It is believed that disturbance of the stress hormone system (the hypothalamic-pituitary-adrenal or...

Detailed Description

Detailed Description: This study will be a parallel design randomized control trial. Duration of study is 10 weeks per subject. Following a baseline assessment of neurocognitive performance, mood sym...

Eligibility Criteria

Inclusion

  • Male \& female outpatients between 19-65 years of age with a diagnosis of bipolar depression. Women must not be currently pregnant and must use a reliable method of contraception for the duration of the study. Subjects must be on stable medication (4 weeks minimum) for their bipolar illness. Subjects must be able to provide written informed consent. Subjects must adequately understand written \& verbal English as rating scales as neurocognitive tests are only in English.

Exclusion

  • Those not meeting the above criteria and those not competent to give informed consent. Women who are currently pregnant. Also excluded: those who have a clinically significant medical illness (including significant head injury with loss of consciousness), those at immediate risk of harming self or others, are currently abusing alcohol or drugs, those with a neurological disorder or uncompensated endocrine disorder, those with a known allergy to mifepristone, those currently being treated with an investigational medication or medication that is contraindicated with mifepristone.

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00359125

Start Date

July 1 2006

End Date

December 1 2010

Last Update

January 22 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of British Columbia, Dept. of Psychiatry

Vancouver, British Columbia, Canada, V6T 1Z3